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Abstract
Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory process of the lung inducing persistent airflow limitation.
Extensive systemic effects, such as skeletal muscle dysfunction, often characterize these patients and severely limit life
expectancy. Despite considerable research efforts, the molecular basis of muscle degeneration in COPD is still a matter of
intense debate. In this study, we have applied a network biology approach to model the relationship between muscle
molecular and physiological response to training and systemic inflammatory mediators. Our model shows that failure to co-
ordinately activate expression of several tissue remodelling and bioenergetics pathways is a specific landmark of COPD
diseased muscles. Our findings also suggest that this phenomenon may be linked to an abnormal expression of a number of
histone modifiers, which we discovered correlate with oxygen utilization. These observations raised the interesting
possibility that cell hypoxia may be a key factor driving skeletal muscle degeneration in COPD patients.
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Introduction
Chronic Obstructive Pulmonary Disease (COPD) is an
inflammatory process of the lung that generates progressive and
largely poorly reversible airflow limitation [1,2]. COPD represents
a high burden on healthcare systems worldwide, since it is the
fourth cause of death and its prevalence is expected to increase in
forthcoming years [3].
The disease is primarily caused by the interplay between inhaled
irritants, most frequently tobacco smoking but also environmental
pollutants, and influenced by genetic susceptibility [4]. In these
patients, the disease results in shortness of breath and contributes to
limitation of exercise tolerance, leading to a decrease in daily
physical activities [5,6]. The latter has a significant deleterious
impact on both clinical outcomes and prognosis [7,8,9]. Rehabil-
itation programs including skeletal muscle training and promotion
of active lifestyles are recommended by all international clinical
guidelines [4] as pivotal elements in the therapeutic strategies for
COPD, but they are insufficiently deployed. One of the reasons for
this is that in a significant percentage of patients, skeletal muscle
dysfunction and muscle wasting are hallmark systemic effects of
COPD [10]. Possibly linked with this, exercise-induced oxidative
stress in COPD muscles is well documented and is likely to be an
important mechanism driving tissue degeneration [11,12,13].
The role of systemic inflammation and myogenesis in skeletal
muscle wasting are still a matter of controversy. However, recent
studies have shown a reduction in the expression of myogenic
genes in COPD muscles [14,15] and a reduction in the ability
to induce their expression in response to training in cachectic
COPD patients [16], providing evidence for a deficiency in tissue
remodelling. It has been proposed that lack of activation of
myogenic pathways may be the result of the over-activation of the
NF-kB pathway induced by systemic inflammatory signals
generated by the lung [14]. This hypothesis is supported by cell
culture and animal experiments, but so far there has been little
evidence that this mechanism is clinically relevant [15]. Analysing
a panel of muscle biopsies from normal and COPD individuals
these authors showed that COPD muscles may be unable to
activate NF-kB targets in response to physical training. Therefore,
the mechanisms leading to skeletal muscle abnormalities in COPD
and the relationship between muscle remodelling and oxidative
damage are still a matter of intense research, and the extensive
literature in this field is unable to support the development of
effective predictive/preventive strategies.
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potentially involved in regulating muscle functionality makes a
systems biology approach a desirable option. Such an approach
aims to model the relationship between key molecular and
physiological variables in healthy and diseased individuals to
derive a testable hypothesis on the disease mechanism.
In this study, we hypothesized that skeletal muscle abnormalities
in COPD may be the result of an imbalance in the physiological
regulation of normal muscle homeostasis induced by systemic
inflammatory mediators and chronic tissue hypoxia. In addition,
we assume that the nature of such alteration might be reverse
engineered by observing the statistical relationship between
variables defining whole body physiology, systemic inflammation
and muscle transcriptional state, with particular reference to cell
bioenergetics and tissue remodelling functions. We based our
analysis on a clinical study representing 12 healthy subjects and 18
age and sex-matched COPD patients, before and after undergoing
an 8 weeks training program. In the latter category we included
patients with preserved muscle mass (COPDN) and patients
showing muscle wasting (COPDL).
We discovered that COPD muscles are characterized by a lack
of correlation in expression of bioenergetic and tissue remodelling
pathways, which included genes specifically involved in myogen-
esis. Our analysis suggests that failure to activate and coordinate
these functions in response to training is associated with a general
lack of activation of NF-kB targets, including many pro-inflam-
matory signals (e.g. IL-1b). We also discovered that expression of
chromatin modification enzymes, known to control muscle
differentiation and energy balance in other biological systems, is
abnormal in COPD muscles and correlated with oxygen avail-
ability. This finding raises the possibility that an epigenetic
mechanism triggered by tissue hypoxia may be the basis of skeletal
muscle wasting in COPD.
Methods
Ethics statement
All animal work has been conducted according to relevant
national and international guidelines and approved by the
University of Birmingham, Medical School ethics committee.
Study groups and design
The 8 weeks training project (TP) was a clinical investigation in
which eighteen COPD patients (6867 yrs, 17 men, FEV1
46612% predicted and PaO2 7560.7 mmHg) with a wide
spectrum of body mass composition and twelve age-matched
healthy sedentary controls (65 yrs, 10 men, FEV1 107614%
predicted and PaO2 9360.7 mmHg) underwent a protocol of
supervised endurance exercise. The inclusion criteria were: 1)
diagnosis of COPD according to GOLD criteria, 2) a stable clinical
condition using standard treatment with bronchodilators and
inhaled corticosteroids, 3) absence of episodes of exacerbation or
oral steroid treatment in the previous 4 months, 4) absence of
significant co-morbidities. All procedures were performed in the
Pulmonary Function Laboratory or the Rehabilitation Unit at the
Hospital Clinic-IDIPAPS. The TP included twelve patients with
stable COPD and normal fat free mass index (FFMI, 21 Kg/m
2)
(COPDN), six COPD patients with low FFMI (16 Kg/m
2) (COPL),
and twelve healthy sedentary subjects (FFMI 21 Kg/m
2). The study
was approved by the Ethics Committee of the Hospital Clinic
(Barcelona, Spain) and all patients gave written informed consent.
Subjects completed all phases of the protocol as well as fully
contributing to the sampling regime.
Significant physiological training effects were obtained using a
standard supervised interval training program. Table S1 and
Figure S1A in Text S1 summarize the characteristics of the study
groups and the training-induced effects on physiological variables.
Constant-work rate exercise at 70% of pre-training Watts peak
(Wpeak) (CardiO2 cycle Medical Graphics Corporation, USA) was
carried out before and after 8-weeks training with cycloergometer,
until pre-training endurance time exhaustion. Measurements before
and after training were obtained at isowork-rate and iso-time.
Measurement of inflammatory mediators in serum
Serum samples obtained at rest before training (Basal-BT) and at
restaftertheeightweekstrainingprogram(Basal-AT)wereanalysed
by Luminex xMAP technology, according to the manufacturer’s
instructions BIO-RAD [17]. A number of cytokines/growth factors
were selected for analysis based on the results of a previous
proteomic study carried out in COPD patients and controls [18]. In
that study [18] a total of 142 cytokines/growth factors were
analysed and 42 of them were differentially expressed in COPD.
Our selection includes 30 analytes covering ,50% of the cytokines/
growth factors previously identified [18], which demonstrated
association to clinical parameters in the same study. The complete
list of proteins measured and the corresponding results of the
analysis is shown in Table S2 and Figure S1B in Text S1.
Expression profiling of muscle biopsies
Skeletal muscle transcriptomics was performed on open biopsies
from the m. vastus lateralis (quadriceps). In all participants these were
obtained at rest, before and after training. RNA was isolated using
RNeasy extraction kits (QUIAGEN, USA) according to the
manufacturer instructions. Microarray gene expression analysis
employingAffymetrixH GeneChip technology wasperformed using
Human U133 Plus2 Gene Chips according to the manufacturer’s
suggested protocols. Data were subsequently subject to quality
control to assess integrity of the RNA using an Agilent Bioanalyzer
(Agilent).Thesedatasetswerenormalised usingthe R librarygcrma,
which converts CEL files using a robust multi-array average (RMA)
expression measure with the help of probe sequences. Data were
quantile normalised [19].
Identification of statistically significant differences in
physiology, serum protein and muscle gene expression
measurements
In order to identify differential changes in physiological and
protein measurements we used two-factor ANOVA with disease
Author Summary
Chronic Obstructive Pulmonary Disease (COPD) is a major
life threatening disease of the lungs, characterized by
airflow limitation and chronic inflammation. Progressive
reduction of the body muscle mass is a condition linked to
COPD that significantly decreases quality of life and
survival. Physical exercise has been proposed as a
therapeutic option but its utility is still a matter of debate.
The mechanisms underlying muscle wasting are also still
largely unknown. The results presented in this paper show
that diseased muscles are largely unable to coordinate the
expression of muscle remodelling and bioenergetics
pathways and that the cause of this phenomena may be
tissue hypoxia. These findings contrast with current
hypotheses based on the role of chronic inflammation
and show that a mechanism based on an oxygen driven,
epigenetic control of these two important functions may
be an important disease mechanism.
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using a threshold of P,0.01. Similarly, genes differentially
expressed between sedentary and trained subjects in the three
populations (healthy, COPDN and COPDL patients) wereidentified
by t-test followed by Benjamimi-Hochberg multiple correction [20]
using a false discovery rate (FDR) threshold of q,10%.
Network inference
Building a model including mRNA, protein and
physiology measurements representing pre and post-
training samples in the 8 weeks study. In order to develop
molecular networks representing the interaction between systemic
and local signals, we have integrated physiology, blood cytokine
levels and muscle mRNA expression measurements by stan-
dardizing each variable, across all samples to have mean of 0 and
standard deviation of 1 using the R package QuantPsyc [21]. After
this procedure, measurements, in different units become directly
comparable. We engineered a global interaction network as the
union of individual network modules, each one of them defined as a
cluster ofvariables linkedby a significant correlation to the profile of
key biomarkers. Such biomarkers, which can be thought of as
network hubs, were chosen to represent biological factors we
hypothesized could be important players in the context of the
clinical problem. These can be summarized in four distinct groups
(for a detailed list see Table S3 in Text S1):
1) Indicators of whole body physiology.
2) Serum protein levels representing systemic inflammatory signals.
3) Muscle mRNA expression profiles of genes encoding for
receptors of cytokines and growth factors, known to play a
role in muscle physiology.
4) Muscle mRNA expression profiles of genes encoding for
enzymes in the glycolysis/gluconeogenesis pathway.
The ability to infer relationships between measured variables
from observational data is at the core of this study. For this reason
we have chosen ARACNE [22], a validated network inference
technique that infers the interaction between pairs of variables
using a measure of correlation called mutual information (MI)
[22,23]. Sparse networks are generated by eliminating non-
significant connections according to a permutation-based statistical
test. Although ARACNE has been used mainly in association with
gene expression data it can be applied to infer interactions
between any variable for which we have quantitative measure-
ments. ARACNE offers numerous advantages over more tradi-
tional measures of correlation, including the ability to spot non-
linear correlations, which are very effective in identifying
biologically relevant connections [22].
In order to infer networks integrating multi-level measurements
from the eight weeks training study we initially used ARACNE to
reconstruct the network neighbourhoods of muscle-expressed
intermediate metabolism genes, immune system and growth factor
receptors genes (measured in muscle biopsies, using microarray
technology), systemic cytokines (using Luminex technology,
measured in serum), and physiological measures (Table S3 in
Text S1). Statistically significant network edges have been selected
using a threshold p,10
27 and no edges have been eliminated
using DPI. Significant connections were identified by applying a P-
value threshold for significant MI values that ensure less than 5%
false positives [24]. Individual networks generated with ARACNE
were merged and the resulting network visualised using the
software application Cytoscape [25], a force-driven layout where
the strength of association in the graph is determined by the value
of mutual information associated with the gene-to-gene connection.
This layout allows the representation of a network structure where
the position of the nodes is determined by the relative strength of
connections. Genes that are strongly linked (i.e. by a high MI value)
will appear closely associated in the graph, whereas genes with a
weak association will be far apart. This procedure was applied to
infer all networks presented in this paper. Moreover, gene lists
derived from statistical analysis of microarray data and from the
analysis of interaction networks have been functionally annotated
using a Fisher test as implemented in the web-based application
DAVID [26]. A Benjamini-Hochberg FDR correction for multiple
testing was applied and a threshold of FDR,0.01 chosen for
selecting significant enrichment of specific Gene Ontology (GO) or
Kyoto Encyclopedia of Genes and Genomes (KEGG) terms in the
different network modules.
Individual network models representing healthy and
COPD muscles. In order to address whether the transcrip-
tional uncoupling between genes involved in tissue remodelling and
bioenergetics was a specific feature of COPD, the procedure
described above was also applied to healthy and COPD muscle
datasets. In order to increase the resolution, we have integrated our
dataset with a similar microarray study recently performed by
Radom-Aizik et al. [27]. This dataset provided microarray data
representing an additional 12 healthy and 12 age-matched COPD
patients pre and post endurance training (12 weeks). This dataset
was quantile normalized using the R library gcrma and microarray
batch effects were corrected using an Empirical Bayes framework
available in R [28].
Network models representing diabetes and muscle
dystrophy muscle biopsies. We have also analyzed two
additional datasets, representing muscle biopsies derived from
patients affected by diabetes and dystrophy. The first microarray
dataset consists of skeletal muscle biopsy samples from 43 age-
matched males with different degrees of glucose intolerance and
including Type 2 diabetes mellitus (available at: http://expression.
gnf.org/) [29]. The dystrophy dataset consist of 84 samples
from patients representing several types of muscle dystrophy
(Facioscapulohumeral muscular dystrophy samples, Becker muscular
dystrophy, Emery Dreifuss muscular dystrophy, from Duchenne
muscular dystrophy) (GEO accession: GSE3307) [30].
Mouse in vivo experiments
To assess the effects of pro-inflammatory cytokines on skeletal
muscle, recombinant mouse IL-1b(10 mg/ml) was injectedin a single
dose into the tail vein of C57BL10 mice at a loading of 100 ng/mouse
(4 animals per group) and samples taken from lateral gastrocnemius
(glycolytic) and soleus (oxidative) muscles 24 h later, with saline-
i n j e c t e da n i m a l sa c t i n ga sc o n t r o l s .S a m p l e sw e r es t o r e da t280uC
until use. RNA was extracted using an RNeasy RNA extraction kit
(QUIAGEN). Microarray expression profiling of four independent
biological replicates was performed using full genome oligonucleotide
arrays (OPERON) after labelling the mRNA with the Cy-Scribe post
labelling kit (Amersham) according to the manufacturer’s instructions.
Genes differentially expressed were identified by a t-test followed by
multiple testing correction (FDR,10%). Significant genes from the
mouse experiment were mapped on the human COPD network by
converting mouse gene identities into their human homologues using
the database Homologene (data was normalised using the same
procedures described for the COPD dataset).
Ingenuity pathway analysis
The gene set represented by those directly connected to growth
factor and cytokine receptor components of the network and
differentially expressed in response to training in healthy indivi-
duals were analyzed using the Ingenuity Pathway Analysis (IPA)
Systems Biology of Muscle Wasting in COPD
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application that enables discovery, visualization, and exploration of
biological interaction networks. Once the gene list was uploaded
to the application, each gene identifier was mapped to its cor-
responding gene object in the Ingenuity Pathways Knowledge Base.
These genes, called focus genes, were overlaid onto a global
molecular network developed from information contained in the
Ingenuity Pathways Knowledge Base. Networks of these focus genes
were then algorithmically generated based on their connectivity
according to the following procedure implemented in the IPA
software application. The specificity of connection for each focus
gene was calculated by the percentage of its connection to other
focus genes. The initiation and the growth of pathways proceed
from the gene with the highest specificity of connections. Each
network had a maximum of 35 genes for easier interpretation and
visual inspection. Pathways of highly interconnected genes were
identified by statistical likelihood. Networks with a Score greater
than 20 and containing more than 60% of focus genes were selected
for biological interpretation. Canonical pathway and functional
term enrichment analysis was performed using the IPA tools, and
significance for the enrichment of the genes within a particular
Canonical Pathway was determined by right- tailed Fisher’s exact
test with a=0.01 using the whole database as a reference set.
Molecular response of mouse quadriceps muscles to
chronic hypoxia conditions
In order to assess whether genes correlated to VO2max in the
clinical study are indeed modulated in response to hypoxia we
have analysed a publicly available microarray dataset representing
the transcriptional response of C57Bl/10 mice to 2 weeks of
chronic hypoxia and compared those with matching controls kept
in normoxic conditions. The dataset was developed by Budak et al.
[31], and it is available in the Gene Expression Omnibus database
under the accession number GSE9400. The details of the overall
design and the dataset can be found in GEO.
For clarity, here we report a concise summary of the exper-
imental design and data generation. Adult male C57Bl/10 mice
weredivided intotwogroups,control(roomcondition) and hypoxic,
over a period of 2 weeks. The hypoxic group was gradually exposed
to lower levels of hypoxia in a specially designed and hermetically
closedhypoxic chamber. A Pegas4000 MF(ColumbusInstruments)
gas blending system was used. The oxygen level was gradually
decreased from 21% to 8% over one week and animals were kept at
8% oxygen for another 7 days. After two weeks animals were
euthanized using CO2 and total RNA was isolated from each
quadriceps femoris (QF) muscle by Tri-Reagent (Ambion, Austin,
TX). Microarray analysis was then performed using an Affymetrix
MouseGenome4302.0Arrayaccordingtothe standard Affymetrix
protocol (Affymetrix, Santa Clara, CA). Data were then quantile
normalized using the R library gcrma [19]. Differentially expressed
genes between normoxic and hypoxic mice were identified using
SAManalysis[32].GenesthathaveanFDRsmallerthan10%were
used to map to the neighborhood of the VO2max in the COPD
network. Genes linked to the GO term ‘‘ chromatin remodeling’’
(represented in Figure S8 in Text S1) were identified using the web-
based tool DAVID [26].
Results
Integration of physiological and molecular responses
acquired in the 8 weeks training study within a network
inference framework
With the aim of developing an initial high level model
representing the relationships between systemic and local signals
we set to integrate all measurements available (physiology, blood
cytokine levels and muscle gene expression measurements) for the
individuals recruited in the 8 weeks training study. These samples
included both pre and post-training blood and biopsy samples.
We then tested the individual network modules generated using
the hubs in Table S3 in Text S1 for enrichment in GO and
KEGG functional terms, which revealed a remarkably coherent
association between target genes and the biological functions of
network hubs. Neighbourhoods of physiological variables, such as
VO2 peak, were mainly enriched in glycolysis/gluconeogenesis,
mitochondria respiratory chain, oxidative phosphorylation (all
positively correlated to VO2 peak), and components of the
ribonucleoprotein complex and RNA processing (negatively
correlated to VO2 peak, Figure S2 in Text S1 and Table S4 in
Text S1). Genes associated with mRNA expression of cytokine and
growth factor receptor hubs were enriched in functions related to
tissue remodelling and immune response (generally positively
correlated with the expression of receptors for growth factors and
cytokines, Table S5 in Text S1), while genes associated with
expression of glycolysis/gluconeogenesis enzymes were mainly
enriched in energy metabolism-related functions (Table S6 in Text
S1). Systemic inflammatory cytokines were weakly connected to
the network (only three significant correlations with genes linked to
physiological measurements).
The union of the individual modules and consequent visualiza-
tion with a force driven layout revealed a clear separation between
two main sub-networks. First, a large sub-network, primarily
representing the association of modules built from cytokine (both
plasma and skeletal muscle) and growth factor receptor hubs and
enriched by tissue remodelling functions. Second, a sub-network
representing the association of modules built with physiology and
skeletal muscle glycolysis/gluconeogenesis hubs and enriched in
energy metabolism genes (Figure 1). Within this sub-network we
found that many of the physiological variables (PaO2, HRPEAK,
HRPEAKper, WATTS, VE, VO2max, VO2maxper, VO2maxkg,
BODE) were highly correlated (Figure S3 in Text S1) and
consequently clustered together (Figure S4 in Text S1) to form a
very compact network module. The other physiological variables
(VEper, FFMI, BMI and age) were separated from this module and
were characterized by a limited number of connections with gene
expression variables (30 genes) (Figure S4 in Text S1).
Uncoupling between expression of tissue remodelling
and bioenergetics modules is a specific feature of
skeletal muscles of COPD patients
In order to assess whether the separation between tissue
remodelling and bioenergetics sub-networks observed in the
network constructed by integrating all measurements in the
training study may be a specific feature of COPD, it was necessary
to developed two separate networks representing healthy and
diseased muscles (Figure 2).
Our analysis, further supported by the integration of an
additional dataset representing an independent and comparable
clinical study (see Methods section for details), confirmed that the
separation between cytokine/growth factor receptors and bioen-
ergetics modules is a specific feature of COPD networks
(Figure 2A, 2B) (Figure S5 in Text S1). In contrast, there was
extensive overlap between the neighbourhood of receptors and
intermediate metabolism in the network constructed from healthy
muscle biopsies (Figure S2C, S2D and Figure S3 in Text S1).
In order to assess whether uncoupling was a general feature of
pathological muscles, network models representing the transcrip-
tional state of dystrophy (Figure S6A and S6B in Text S1) and
diabetic muscles (Figure S6C and S6D in Text S1) were also
Systems Biology of Muscle Wasting in COPD
PLoS Computational Biology | www.ploscompbiol.org 4 September 2011 | Volume 7 | Issue 9 | e1002129Figure 1. Network integrating multi-level measurements in the 8 weeks training study. The figure shows the network representing the
relationship between physiological measurements, serum cytokine levels and mRNA expression profiles in the muscle, following ARACNE analysis of
the 8 weeks training dataset. Panel A shows an outline of the network topology where individual network hubs have been annotated. Red nodes
represent genes coding for receptors for growth factors and immune system mediators, blue nodes represent physiological measurements, brown
Systems Biology of Muscle Wasting in COPD
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bioenergetics sub-networks were localized in close proximity. It was
remarkable that even in a situation where muscle functionality is
severely impaired by the lack of important structural components, a
condition typical of muscle dystrophy, energy and tissue remodel-
ling functions still remain co-ordinately regulated. This observation
further strengthens the concept that uncoupling between muscle
remodelling pathways and bioenergetics is a specific feature of
COPD muscles.
The molecular response to endurance training highlights
a failure of diseased muscles to transcriptionally regulate
tissue remodelling and bioenergetics
Healthy individuals responded to training by modulating
expression of a relatively large number of genes (3908, Figure
S7A in Text S1) compared to COPDN (953, Figure S7B in Text S1)
and to COPDL patients (6 genes). There was a significant overlap
(36%,FDR,10%)at the gene level and an almost complete overlap
at the pathway level (Figure S7 in Text S1) between the response to
training in COPDN and healthy subjects whereas none of the six
genes differentially regulated in the COPDL group were modulated
in healthy and COPDN individuals (Figure S7C in Text S1).
In order to identify which part of the network was modulated
in response to training, these differentially expressed genes
were mapped onto the integrated network described previously
(Figure 1). Genes that were up-regulated after training appear to
cluster primarily in proximity to receptors for the cytokines IL-1
(IL1R), CSF1 (CSF1R), plasminogen (ENO1) and the key receptor
for the pro-angiogenesis growth factor VEGF (VEGFR2)
(Figure 3A). A second cluster that is also predominantly populated
by genes up-regulated in response to training represents the
neighbourhoods of glycolytic enzymes (Figure 3A) and to the
epidermal growth factor receptor (EGFR). In contrast, genes that
are either up or down-regulated in response to training populated
the neighbourhood of physiological variables, representing energy
(up regulated) and mRNA processing (down-regulated) functions.
The transcriptional response of COPDN muscles to training
followed a very similar pattern although as reported in Figure S5C
in Text S1, the number of genes involved was much lower
(Figure 3B). As mentioned previously, COPDL patients do not
respond to training with a detectable change in the transcriptional
state of the muscle (Figure 3C). In addition to the transcriptional
uncoupling described above, the transition between healthy and
diseased individuals is therefore characterised by a reduction in the
ability to transcriptionally regulate expression of genes in both
tissue remodelling and bioenergetics pathways.
To better characterize molecular networks associated with the
growth factor and cytokines components of the network (see
Figure 1 and Figure 2) directly connected to receptor hubs and
differentially expressed in response to training in healthy individuals
(predominantly located in the lower part of the network), we
selected and used these genes as input for the Ingenuity Pathway
Analysis (IPA) software. The analysis identified 17 networks (see
method section for details of the procedure) (Table S7 in Text S1).
Among the most significant findings, two interconnected networks
linked the transcription of several cytokines (IL1, TNFa, IFNc,
CCL2) and activation of the NF-kB complex (Figure 4A), leading to
the activation of several NF-kB targets related to connective tissue
formation (Figure 4B). Figure 4C shows the relationship between
upregulation of gap junction complexes (JAM, JAM2, JAM3 and
TJP1) and activation of important structural components of muscle
fibres (e.g. tropomyosin). The network in Figure 4D shows the
important functional link between activation of several Rho
GTPases and muscle development, represented by genes encoding
for a component of the hexameric ATPase cellular motor protein
myosin (MYL5) and (MYH10).
Although not all captured by our network model, 6 myogenic
markers were found to be regulated in response to training (Table
S8 in Text S1). Five of these were up-regulated. Consistent with
what was previously observed (above), the training-induced
expression of all the genes represented in these networks was
defective in COPD individuals (Figure S4 and Table S8 in Text
S1).
Interleukin-1 promotes activation of tissue remodelling in
vivo and mirrors the effect of training in healthy human
subjects
Because of the strong correlation between expression of IL-1
receptor and genes involved in muscle remodelling and the
networks identified by the Ingenuity analysis, we reasoned IL-1
might be responsible for inducing a significant component of the
transcriptional response to training observed in healthy individ-
uals. In order to test this hypothesis we performed intra-venous
injections of IL-1b in mice, and characterised the transcriptional
response in both glycolytic and oxidative muscles using microarray
expression profiling.
The response of mice to injection of IL1b supported our initial
hypothesis. IL-1b treatment induced within 24 hours the up-
regulation of 336 genes in oxidative muscle, whereas in glycolytic
muscles it induced the up-regulation of 263 genes and the down-
regulation of 201 genes (Table 1). Genes up-regulated in both
muscle fibre types were enriched for structural components of the
sarcomere (ACTA1, NEB, CRYAB, ANKRD2). Apart from this,
the response of the two muscle fibre types was very different.
Oxidative muscles up-regulated genes encoding for components of
the extracellular matrix and organ development including angio-
genesis (SOX18, VEGFA, SERPINF1, ANXA2, PTEN, ENG),
whereas glycolytic muscles modulated genes involved in oxidative
phosphorylation (COX8A, COX5A, NDUFB8, NDUFB5, NDUFS4,
NDUFV2) and ribosomal components (Ribosomal protein chains
10A,s5 and I37A, and mitochondrion ribosomal protein chains 35
and 45).
The high percentage of differentially expressed genes encoding
for tissue remodelling functions (extracellular matrix components,
organ structure development, cell communication) and bioener-
getics (oxidative phorphorylation) which included the oxygen
sensitive regulator HIF-1, suggested that IL-1b has the potential
to reproduce a component of the physiological transcriptional
response to training that is defective in COPD patients.
In order to assess this hypothesis, we mapped genes differen-
tially expressed in the IL-1 b mouse experiment on the human
interaction network represented in Figure 1. 78% and 68% (265
and 317 genes) of the genes modulated in response to IL-1b
treatment in oxidative muscle and glycolytic muscle, respectively,
in mice mapped on to the human dataset. Of these, 34 genes were
up-regulated after endurance training in healthy individuals
nodes represent serum cytokines, and green nodes represent gene expression of enzymes in the glycolysis and gluconeogenesis pathways. Panel B
shows all nodes in the network (representing 16350 genes or measurements). The colour of nodes follows the same code as panel A. In addition
yellow nodes represent genes in common between cytokine and growth factor and glycolysis/gluconeogenesis network hubs.
doi:10.1371/journal.pcbi.1002129.g001
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PLoS Computational Biology | www.ploscompbiol.org 6 September 2011 | Volume 7 | Issue 9 | e1002129Figure 2. Healthy and COPD specific networks. The figure shows interaction networks built using solely expression profiling data representing
healthy (panels A and B) or COPD (panels C and D) muscle biopsy mRNA profiles. For comparison with Figure 1, the network representing integrated
healthy and COPD samples has been represented in Panels E and F. Figure layout and the colour coding are identical to Figure 1.
doi:10.1371/journal.pcbi.1002129.g002
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PLoS Computational Biology | www.ploscompbiol.org 7 September 2011 | Volume 7 | Issue 9 | e1002129Figure 3. Training response of healthy and COPD individuals visualized on the integrated 8 weeks training network. The networks
represent the genes up-regulated (marked in red) and down-regulated (marked in blue) mapped on to the interaction map inferred using the 8
weeks training multi-measurement dataset (shown in detail in Figure 1). Panel A shows genes differentially regulated after training in healthy
individuals. Panel B shows genes differentially expressed after training in N-BMI COPD patients. Network hubs representing genes up-regulated (red)
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PLoS Computational Biology | www.ploscompbiol.org 8 September 2011 | Volume 7 | Issue 9 | e1002129(Figure 5). A significant proportion of these genes were, in
oxidative muscle, also directly connected with the receptor for
Interleukin 1 in the integrated network model. This observation
further validates the model and supports a role for IL-1b in the
physiological response to training.
Decreased training-induced expression of NF-kB target
genes in COPD muscles
The lack of activation of tissue remodelling functions in COPD
muscles, including the component linked to IL-1b signalling, may
be a consequence of the inactivation of myogenic pathways due to
or down-regulated (blue) are listed on the side of the relevant sub-networks. The drastic reduction in the molecular response to training associated
with the cytokine and bioenergetics clusters is evident. Panel C shows the lack of response to training in COPDL patients.
doi:10.1371/journal.pcbi.1002129.g003
Figure 4. Ingenuity networks regulated by endurance training. This figure shows the most important findings derived from Ingenuity
analysis using genes that are differentially expressed in response to training in healthy individuals and connected to receptor hubs in the previously
inferred network. Panel A and Panel B represent two interconnected networks linked the transcription of several cytokines (IL1, TNFa, IFNc, CCL2) and
activation of the NF-kB complex (Panel A), leading to the activation of several NF-kB targets related to connective tissue formation (Panel B). Panel C
shows the relationship between upregulation of gap junction complexes (JAM, JAM2, JAM3 and TJP1) and activation of important structural
components of muscle fibres (e.g. tropomyosin). Panel D shows the important functional link between activation of several Rho GTPases and muscle
development, represented by genes encoding for a component of the hexameric ATPase cellular motor protein myosin (MYL5) and MYH10.
doi:10.1371/journal.pcbi.1002129.g004
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of pro-inflammatory cytokines [14]. We reasoned that if this
hypothesis were correct, we should observe over expression of a
number of NF-kB target genes in diseased muscles.
We had previously observed that a number of NF-kB targets,
identified by the IPA software in the ‘tissue remodelling’ section of
the network, were up-regulated during training in healthy
individuals, but failed to respond in COPD patients (Figure 4A).
Although interesting, this observation was based on a loose
definition of NF-kB targets, as many connections reported in the
Ingenuity database are indirect. We therefore further tested the
NF-kB over-activation hypothesis by analyzing expression of 94
experimentally validated targets of NF-kB (Table S9 in Text S1).
Against the working hypothesis, we could not identify any NF-kB
target gene differentially regulated between normal and diseased
muscles. On the contrary, we could detect 13 genes that were
differentially regulated in response to training in healthy indi-
viduals (all up regulated, 10%FDR and fold.1.5) but not in
COPD individuals with normal or low BMI (Table 2). These
observations clearly do not support the over-activation hypothesis.
On the contrary, they suggest that in COPD muscles training-
induced activation of NF-kB is repressed.
Expression of epigenetic histone modifiers discriminates
between healthy and diseased muscles and is correlated
with peak oxygen consumption
In order to explore an alternative hypothesis that may explain
muscle wasting in COPD patients, we performed an unbiased
analysis to identify functional pathways differentially modulated
between healthy and diseased muscles. We therefore used two-
factor ANOVA, taking into consideration both disease and
training.
Consistent with the analysis described above, we identified tissue
remodelling and energy-associated pathways as significantly
differentially expressed for both factors analysed (Table S10 in
Text S1). However, one additional category of 20 chromatin
modification enzymes were also differentially expressed (Table 3).
Among these we could identify four histone deacetylase enzymes,
which are known to be particularly relevant for controlling
expression of muscle differentiation (HDAC9 and HDAC4,
SIRT2) and bioenergetics (SIRT3) related genes. Consistent with
their potential role in COPD muscle wasting, expression of these
genes was sufficient to discriminate between diseased and healthy
muscles with great accuracy (90% of cross-validated prediction
accuracy using a K-nearest neighbour - model) (Figure 6A). By
mapping them on the network model described in Figure 1 we
discovered that they localized close to VO2peak, (Figure 6B)
suggesting that their transcription may be up-regulated by oxygen
availability and/or oxidative capacity in the skeletal muscle.
Genes predicted to be linked to VO2max ARACNE are
induced in a mouse model of chronic hypoxia
In order to elucidate whether genes linked to VO2max in our
network model are part of the physiological response to hypoxic
conditions we analyzed a public domain microarray study de-
veloped by Budak et al. (GEO: GSE9400) [31] which represents
the response of murine skeletal muscles to 2 weeks hypoxic
conditions.
We discovered that 45% of genes connected to VO2max in the
network model were transcriptionally regulated in the mouse
model of hypoxia and that a striking 82% of these were regulated
in the direction predicted by the network analysis (Figure 7).
Among these, we found the genes encoding for the chromatin
modifiers HDAC4 and SIRT3. HDAC4 is up-regulated, whereas
SIRT3 is down-regulated in hypoxic mice compare to normal
(Figure 7), which is consistent with the sign of the correlation with
VO2max observed in the clinical study (Figure 6A and 6C).
Interestingly, we also discovered that many other genes encoding
for chromatin modifiers were differentially expressed in response
to hypoxia (Figure S8 in Text S1).
Discussion
The networks we have developed represent the first model
linking molecular and physiology measurements in skeletal muscle
of COPD patients. It provides convincing evidence that a failure to
co-ordinately activate expression of several tissue remodelling and
bioenergetic pathways is a specific landmark of diseased muscles.
Moreover, our model is consistent with the view that the abnormal
expression of a number of histone modifiers potentially regulated
by oxygen availability may be responsible for alterations in both
tissue remodelling and bioenergetic functions. This hypothesis has
important implications as it places cell hypoxia and oxidative
capacity as the main drivers for skeletal muscle abnormalities in
COPD patients.
Response to training in healthy and diseased muscles
We identified several pathways which are transcriptionally
regulated in healthy individuals in response to training. These
involve the up-regulation of several tissue remodelling genes/
pathways (Plasminogen receptor, VEGF, pro-inflammatory signals
such as IL1) as well as modulation of energy and ribosome
biogenesis functions. Without exception, the exercise-induced
modulation of these pathways is severely impaired in COPD
individuals.
The Ingenuity pathway analysis has revealed several detailed
mechanisms associated with the inflammation and growth factor
receptor component of the network we have inferred. Two of these
networks (Figure 4A and 4C) are part of a larger network linking
Table 1. Response to IL1 injection in oxidative and glycolityc muscle.
Tissue type sign # Functional annotation
Oxidative muscle up 257 GOCC ECM (64). GOCC sarcomere (7). GOCC lysosome (8). GOBP anatomical dev
structure (41). GOBP angiogenesis (6). GOMF oxidoreductase activity (18).
Glycolitic muscle up 170 GOCC myosin complex (5). GOCC sarcomere (6). GOBP generation of precursor
metabolites and energy (13). KEGG oxidative phos. (8) GOCC mit (20). GOBP
gluconeogenesis (5).
Glycolitic muscle down 150 GOCC extracellular space (23). GOBP protein transport (10). GOBP metabolic process
(60). GOCC Mit (4)
Functional annotation of genes changing in response to IL1 injection in oxidative and glycolityc muscle. These functions are not necessarily significantly enriched.
doi:10.1371/journal.pcbi.1002129.t001
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PLoS Computational Biology | www.ploscompbiol.org 10 September 2011 | Volume 7 | Issue 9 | e1002129Figure 5. Effects of IL-1b in mouse glycolytic and oxidative muscles. This figure describes the effects of recombinant interleukin 1 on the
transcriptional state of glycolytic and oxidative muscles. Panel A represents the heatmap of expression profiles in human muscle biopsies of genes
that are differentially regulated in response to training in humans and also induced by IL1b in mouse muscles. Panel B shows the localisation of genes
up-regulated in oxidative and glycolytic muscles on the COPD interaction network represented in Figure 1.
doi:10.1371/journal.pcbi.1002129.g005
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IFNc to the training induced up-regulation of several components
of the extracellular matrix in healthy subjects. Although circulating
concentration of IL-1b are largely unaffected by exercise there is
evidence of increased local IL-1b levels within skeletal muscle,
likely in response to micro-injury of skeletal muscle with increased
activity [27]. The in vivo experiment we have performed show that
indeed a component of the transcriptional response observed in
healthy individuals and defective in COPD patients may be
mediated by interleukin-1b. Moreover, we found that mouse
glycolytic and oxidative muscles respond similarly to IL-1b in
respect to the up-regulation of structural components of the muscle
but diverge in the regulation of genes involved in energy
metabolism and ubiquitination (up-regulated in glycolytic muscle),
or extracellular matrix and tissue remodelling including angio-
genesis (up-regulated in oxidative muscles).
Patients with mild to moderate COPD have a greater
proportion of fatigue-susceptible anaerobic (glycolytic Type II)
relative to fatigue-resistant aerobic (oxidative Type I) fibres,
suggesting a slow-to-fast transition. It has been proposed that
,27% Type I and .29% Type IIx fibres offers a pathological
threshold for COPD [33]. This is consistent with a shift towards a
more glycolytic enzyme profile, and would contribute to an
increase in skeletal muscle fatigability [34]. Although individual
fibre phenotypes are well conserved among mammals virtually all
human skeletal muscles are of mixed composition, hence mouse
muscles with discrete metabolic profiles were used to identify
differential responses to IL-1b according to metabolic type.
A mechanistic link between the activity of these tissue
remodeling pathways and myogenesis is well supported by the
current literature. For instance, the plasminogen receptor ENO1
has been demonstrated to be an important component of skeletal
myogenesis by concentrating and enhancing plasmin generation of
the cell surface [35]. Interestingly, ENO1 KO mice show severe
defects in muscle regeneration following injury [31]. Components
of the extracellular matrix, which are induced by signaling from
many of the receptors present in the network are also mecha-
nistically linked to myopathies. For example, Col6a1–deficient and
Col15a1-deficient mice have a muscle phenotype that strongly
resembles human myopathies [36,37].
Inflammatory and chemo-attractant mediators are also known
to be key factors in driving muscle remodelling in the normal
physiological response to training [38] and in response to trauma
[35]. In the latter, IL1b also promote phagocytosis of trauma-
induced cellular debris by macrophages, which themselves can
continue to secrete this cytokine up to 5 days post-injury [39].
CCR2 null mice with cardiotoxin induced injury has been shown
to have a delayed angiogenesis and VEFG production compared
to wild type mice with muscle fibre size increase observed only
after restoration of tissue VEGF [40]. Other studies have also
shown the crucial role of VEGF in angiogenesis and in muscle
regeneration [41,42].
There is also strong evidence that bioenergetics and tissue
remodelling pathways are linked [43]. It has been shown that
genes coding for components of collagen V and collagen VI play
an important regulatory role in ECM maturation, where reduced
expression promotes apoptosis, mitochondrial dysfunction and
muscle degeneration [43]. Other studies have shown that
bioenergetics knockouts, such as H6PD null mice is responsible
for inducing severe skeletal myopathy by altering sarcoplasmic
reticulum redox state [44].
Decreased training induced expression of NF-kB target
genes in COPD muscles
A number of in vitro and in vivo studies have been used in the past
to support the hypothesis that a systemic inflammation-driven
mechanism leads to inactivation of myogenic pathways in COPD
muscles. Our analysis is the first attempt to challenge this
hypothesis using genome-wide data, and in a clinically relevant
setting. We could not find evidence of over-expression of NF-kB
target genes in COPD muscles. On the contrary, we saw that a
subset of direct (Table 2) and indirect targets (Figure 4A) of NF-kB
were up-regulated in healthy individuals in response to training
but not in COPD patients (p,0.05). These results are consistent
with a recent observation demonstrating failure to activate NF-kB
in response to acute training in a small subset of COPD patients
[15]. Taken together, these results suggest that training-associated
inactivation rather than over activation of NF-kB may be a feature
of diseased muscles.
Additional observations also argue against a primary role of
chronic inflammation in muscle wasting. For example, although
we clearly have identified increased levels of cytokines in COPD
patients (Figure S1B in Text S1) with respect to normal
individuals, we could find little correlation between the concen-
Table 2. NFKB Targets in response to training in healthy
muscle.
genes FOLD CS-CT FDR
TFPI2 1.88 0.02
PLAU 1.62 0.02
CD74 1.60 0.03
CCL2 1.69 0.04
ENG 1.41 0.04
CCND1 1.45 0.07
NQO1 1.69 0.08
CD44 1.80 0.09
NFKB Targets which are significantly different in response to training in healthy
patients.
doi:10.1371/journal.pcbi.1002129.t002
Table 3. Functional annotation of genes identified by two-factor ANOVA.
Functional Category Genes in the Function ( 10% FDR)
GOCC Chromatin remodelling complex (disease factor) APPL1, ARID1A, ARID1B, CHD4, CIR1, HDAC4, HDAC7, HDAC9, MBD2, MTA1, PHF21A,
RSF1, SIN3A, SIRT2, SIRT3, SMARCA4, SMARCB1, SNARCE1, SUDS3, TBL1XR1
GOCC histone deacetylase complex (exercise factor) APPL2, CHD3, CHD4, GATAD2A, HDAC1, HDAC11, HDAC3, HDAC4, HDAC5,
LOC642954, MBD3, NRIP1, RBBP4, RBBP7, RERE, SAP18, TAL1, TBL1XR1
Functional enrichment of genes that are significantly differentially expressed in both disease and training.
doi:10.1371/journal.pcbi.1002129.t003
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PLoS Computational Biology | www.ploscompbiol.org 12 September 2011 | Volume 7 | Issue 9 | e1002129Figure 6. Expression of chromatin modification enzymes in COPD and healthy muscles. Panel A represent the close localization of histone
deacetylase enzymes to VO2max in the inferred network. Panel B is a 3D plot representing the expression of histone deacetylase enzymes and the
separation between disease and healthy muscles. Panel C, D, E and F represent the scatterplots between VO2max and the expression of histone
deacetylase enzymes.
doi:10.1371/journal.pcbi.1002129.g006
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implying that these signals may have a smaller effect on muscle
physiology than previously thought. This latest observation is
consistent with previous reports showing that TNFa levels
measured in COPD muscles were not significantly higher than
in healthy muscles [45].
Is there an epigenetic basis for muscle wasting in COPD?
Since the NF-kB over-activation hypothesis is unlikely to explain
the inhibition of muscle remodelling observed in COPD, can we
propose an alternative mechanism for muscle wasting in COPD?
There are several pieces of evidence in favour of the hypothesis
that an imbalance in expression of oxygen-correlated chromatin
modifying enzymes, which we have shown to be a landmark of
COPD muscles, could explain failure to modulate both tissue
remodelling and bioenergetic functions in response to training. In
Figure 6 we have shown that the expression of SIRT2, SIRT3,
HDAC4 and HDAC9 is sufficient to discriminate healthy and
diseased muscles. At the individual gene level, healthy muscles are
characterized by a higher expression of HDAC9, SIRT3 and by a
lower expression of HDAC4 (Table 4) with respect to COPD
muscles.
The role of HDAC9 and HDAC4 in muscle development is well
documented [46]. For example, HDAC9 is a transcriptional
repressor involved in feedback control of muscle differentiation,
acting in concert with MEF2 to repress activity-induced genes
[47], while HDAC4 is up-regulated in pathological conditions
such as muscle denervation [48], and it has been described to be a
critical regulator of muscle atrophy by activation of E3 ubiquitin
ligases [49]. It is possible, therefore, that a lower expression of
HDAC9 and a higher expression of HDAC4 in COPD muscles
may be linked to a reduced ability to activate muscle remodelling.
Abnormal expression of SIRT2 may also contribute to a failure to
activate an appropriate muscle remodelling response. SIRT2 is a
NAD
+-dependent histone deacetylase that regulates muscle gene
expression and differentiation by forming a complex with MyoD
[50]. When over-expressed, this retards muscle differentiation.
Conversely, cells with decreased SIRT2 differentiate prematurely.
Interestingly, the activity of SIRT2 is dependent on the redox state
of the cell [50], which showed evidence of being abnormal in
COPD muscles [11,12,13]. In the neighborhood of SIRT2, we
have also identified TXN2 that is known to play an important role
in protection against oxidative stress [51]. Similarly, GAB1 is
shown to play a role in oxidative stress signaling [52] and it is
identified in the neighborhood of HDAC9 in the network. Since
changes in ROS production are known to influence the expression
of HDACs [53], the network we have identified may represent this
important control mechanism.
SIRT3 is a NAD
+-dependent histone deacetylase that may
account for the characteristic loss of transcriptional modulation of
bioenergetic genes in response to training in COPD muscles.
SIRT3 is localized in the mitochondrial matrix, where it regulates
the acetylation levels of metabolic enzymes, including acetyl
coenzyme A synthetase 2 [54,55]. Mice lacking both SIRT3 alleles
show hyperacetylation of several mitochondrial proteins, associat-
ed with decreased levels of fatty-acid oxidation, and display a
Figure 7. Genes represented in the neighborhood of VO2max
are transcriptionally regulated in a mouse model of hypoxia.
This heatmap represent the expression of genes in the neighborhood of
VO2max that are also differentially expressed in skeletal muscles, in a
mouse model of hypoxia. It shows that the majority of these genes
(82%) are regulated in the direction predicted by the network we
developed (Figure 1). The HDAC4 and SIRT3 genes are among these
and are highlighted in red. Genes that are not modulated in the
direction we predicted are shaded in grey.
doi:10.1371/journal.pcbi.1002129.g007
Table 4. Chromatin remodeling complex genes in healthy
and disease muscle.
Gene Symbol Fold Disease vs. Healthy ANOVA Factor Disease (FDR)
HDAC9 2.30 6.61e-5
HDAC4 21.48 0.05
SIRT2 1.27 0.0016
SIRT3 1.31 0.02
Genes that are significantly different between healthy and disease belonging to
the functional category of GOCC Chromatin remodeling complex.
doi:10.1371/journal.pcbi.1002129.t004
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leading to reduction in basal levels of ATP in several organs [56].
These and other data implicate protein acetylation as an
important regulator of mitochondrial function in vivo, and it is
therefore feasible that an altered expression of SIRT3 in the
muscles of COPD individuals may contribute to the observed
imbalance in mitochondria functionality. It is interesting that
SIRT3 in our model is positively correlated with VO2peak,
suggesting that the lower levels of expression of this enzyme
observed in COPD muscles may be the consequence of tissue
hypoxia. Consistent with this, histone deacetylase (HDAC)
inhibitors reduce HIF-1a protein expression leading to down-
regulation of VEGF and other angiogenesis-related genes [57],
potentially explaining the reciprocal relationship between extent of
muscle capillarity and the degree of COPD [58]. The abnormal
expression of a relatively small number of histone modifying
enzymes could therefore account for a wide spectrum of abnormal
responses observed in the muscles of COPD patients, and may also
explain the limited efficacy of training as a therapeutic option.
This view is supported by our observation that indeed hypoxia
induces modulation of a number of chromatin modifiers in a
mouse model of chronic hypoxia (Figure S8 in Text S1) and that
indeed SIRT3 and HDAC4 are among them (Figure 7).
Conclusion
Our work represents the most accurate system level represen-
tation of COPD muscles to date. Further work is, however, needed
to elucidate the precise mechanism for muscle inactivation. If the
mechanism for muscle wasting suggested by our observations on
HDACs were to be validated in a clinical setting this would open
up a very exciting therapeutic avenue. The use of non-toxic
histone deacetylase inhibitors such as valproate has already shown
promising in treatment of haematological cancer [59,60,61], and
may help to restore mitochondrial functionality and the ability to
activate muscle remodelling in COPD patients. In this context it is
possible that the appropriate pharmacological regime coupled
with physical rehabilitation may lead to recovered muscle
functionality, and improved quality of life.
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